Brivudine

Chemical formula: C₁₁H₁₃BrN₂O₅  Molecular mass: 333.135 g/mol  PubChem compound: 446727

Therapeutic indications

Brivudine is indicated for:

Shingles

Population group: only adults (18 years old or older)

Brivudine is used in adults with no abnormality of their immune system (the body’s defences) for the early treatment of shingles (herpes zoster).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Brivudine is contraindicated in the following cases:

Chemotherapy, immunosuppressants

Antineoplastic and immunomodulating agents

Pregnancy

Pregnancy

Lactation

Lactation

Flucytosine

Flucytosine

5-fluoropyrimidines

Pyrimidine analogues

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈